EP-100 + Paclitaxel to Overcome Taxane Resistance in Patients With Recurrent LHRH-receptor Expressing Ovarian Cancer.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.15_suppl.5582
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2015
Authors
Publisher
American Society of Clinical Oncology (ASCO)